| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000021204 |
| Receipt No. | R000024453 |
| Official scientific title of the study | Basic analysis of cornea/sclera in cornea, sclera disease and Chorioretinopathy |
| Date of disclosure of the study information | 2016/02/25 |
| Last modified on | 2016/08/28 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Basic analysis of cornea/sclera in cornea, sclera disease and Chorioretinopathy | |
| Title of the study (Brief title) | analysis of cornea and scleral tissue | |
| Region |
|
|
| Condition | ||
| Condition | cornea, sclera disease and chrioretinopathy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Tissue from horioretinopathy(include uveitis), diabetic retinopathy, cornea disease, scleritis, retinal detachment, retinal vein occlusion, malignant lymphoma, epiretinal membrane were collected during operation, which should become the useful tool for curing the disease. Collected samples were tested by several basic analysis such as real time PCR, ELISA, western blotting and tissue specimen. The sample of cornea and sclera were collected by scissors. We investigate the new findings and treatment for the disease that dose not have any effective treatment. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | We would not develop the drugs and new treatment method. So, we could not asses from this clinical test. We could asses and hold the clinical condition from the tissue that was collected during operation. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | over 20 year old (if patient need for diagnosis, age should not be mattered. Parents should sing for the agreement form)
cornea and sclera disease with informed consent and agreement |
|||
| Key exclusion criteria | with severe disease
|
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuichi Maruyama |
| Organization | Tohoku University Hospital |
| Division name | ophthalmology |
| Address | 1-1 Seiryo-machi Aoba ward, Sendai |
| TEL | +81-22-717-7294 |
| maruyama-k@oph.med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Kazuichi Maruyama |
| Organization | Tohoku University Hospital |
| Division name | Ophthalmology |
| Address | 1-1 Seiryo-machi Aoba ward, Sendai |
| TEL | +81-22-717-7294 |
| Homepage URL | |
| maruyama-k@oph.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Tohoku University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tohoku University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 京都府立医科大学
理化学研究所 LSIメディエンス |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | The tissue collected from patients randomly and prepare for histological section, to detect the infection with using PCR, analyze the cell population. This test perform as forward looking research to detect the relationship between the results and pathogenesis. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024453 |